Home › Myelofibrosis › Pennsylvania › Pittsburgh
Myelofibrosis clinical trials in Pittsburgh, PA
3 studies for Myelofibrosis are looking for participants at sites in and around Pittsburgh (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
RecruitingPhase 3
- University of Pittsburgh Medical Center, Pittsburgh
- Allegheny Health Network Cancer Institute - West Penn Hospital Location, Pittsburgh
A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
RecruitingPhase 3
- UPMC Hillman Cancer Center ( Site 6004), Pittsburgh
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
RecruitingPhase 3
- West Penn Hospital, Pittsburgh
Myelofibrosis trials in other cities
- Houston, TX19 studies
- New York City, NY18 studies
- Durham, NC12 studies
- Boston, MA12 studies
- Columbus, OH11 studies
- Seattle, WA11 studies
- Salt Lake City, UT10 studies
- Miami, FL10 studies
- Cleveland, OH9 studies
- Tampa, FL9 studies
- Atlanta, GA9 studies
- Nashville, TN9 studies
Other studies in Pittsburgh
- Non-Small Cell Lung Cancer48 studies
- Cancer (all types)41 studies
- Breast Cancer39 studies
- Colorectal Cancer32 studies
- Metastatic Cancer31 studies
- Melanoma31 studies
- Ovarian Cancer30 studies
- Endometrial Cancer23 studies
- Lung Cancer23 studies
- Prostate Cancer23 studies
- Stroke22 studies
- Head and Neck Squamous Cell Carcinoma22 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.